Navigation Links
Biochemist unlocks gene's role in breast-tumor growth
Date:4/30/2010

This release is available in French.

New research led by McGill Biochemist Dr. William Muller helps explain why breast-milk cells lose their structure, causing them to clump up in strange ways (photos available) and sometimes become cancer tumors. With the support of Chen Ling and Dongmei Zuo at McGill's Goodman Cancer Centre, Muller has discovered how one particular gene regulates epithelial cells cells that normally form in sheets and are polarized to enable the transport of molecules in a single direction. It's this loss of polarity that is thought to play an important role in breast tumor development. Scientists at the Ontario Cancer Institute (Princess Margaret Hospital's research arm) and Cold Spring Harbor Laboratory in New York State also contributed to the findings.

By using mouse models, Muller discovered that the cells do not form neat structures when the gene malfunctions. "In fact, the first mouse model had a skin defect and was completely incapable of forming sheets of epithelial cells. This gene is frequently lost in breast cancer, significant proof that this gene might play an important role," he said.

The research published today in Genes and Development shows that if the gene is reintroduced into a tumour, polarity can be restored. "This is an interesting first step along this particular path," Muller said, pointing out that the gene functions by working with more than 40 various proteins, of which only one, a scaffold protein, has been identified. Proteins, he said, play various roles in our body, from maintaining cell shape and function through to driving chemical reactions, immune responses and growth.

"We have many other steps to take before we can say this path will lead to a treatment or cure."


'/>"/>

Contact: William Raillant-Clark
william.raillant-clark@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert  

Page: 1

Related biology news :

1. Biochemist researching computer models of protein structure that help high school, college students
2. Stimulus funding helps K-State biochemist study eyes lens in diabetes, galactosemia patients
3. Springer partners with the American Society for Biochemistry and Molecular Biology
4. ASBMB Annual Meeting to feature talks on the biochemistry of aging
5. UC Riverside biochemist to study how crops can increase protein production
6. Phytoplankton cell membranes challenge fundamentals of biochemistry
7. Biochemistry of human physiology in health and disease is focus of updated clinical text
8. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
9. UC Riverside biochemists devise method for bypassing aluminum toxicity effects in plants
10. Computational biochemist uncovers a molecular clue to evolution
11. Biochemists manipulate fruit flavor enzymes
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biochemist unlocks gene's role in breast-tumor growth
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/24/2016)... ... 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona combed ... pleural mesothelioma. Their findings are the subject of a new article on the Surviving ... signposts in the blood, lung fluid or tissue of mesothelioma patients that can help ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology: